There are problems with the vaccination of the population against coronavirus in the United States: the vaccination campaign is significantly behind schedule because of logistics.
Initially, authorities were going to vaccinate 20 million Americans by the end of 2020.
In Florida, for example, medics used less than a quarter of the available doses. In Puerto Rico, deliveries were disrupted by staff departures over Christmas. In California, doctors reported a shortage of the drug.
The publication notes that the heads of local health departments and hospital chief physicians cite several reasons for this. One is the vacation season in connection with Christmas and the New Year. The second reason is the delay in vaccine deliveries to the state-run nursing homes. The backlog is also affected by the workload of nursing home staff and health officials. They don’t have enough time to detail the vaccination campaign and distribute the drugs.
Earlier, Trump revealed a deadline for shipping the U.S. coronavirus vaccine around the world. “Early next year, we will provide the vaccine to all U.S. citizens. Shortly thereafter, we will begin delivering it to the world,” he said during his New Year’s address.
On Dec. 31, the World Health Organization (WHO) placed the Pfizer/BioNTech coronavirus vaccine on the list of drugs recommended for emergency use.
On December 13, guidelines from the federal Centers for Disease Control and Prevention (CDC) approved the use of BioNTech and Pfizer vaccine in the U.S. for emergency use. The first person to receive the BioNTech and Pfizer vaccine in the U.S. was New York City nurse Sandra Lindsay, who has worked for the past ten months with COVID-19 patients. Then on December 19, U.S. authorities approved a second coronavirus vaccine, Moderna, for use in the country…